# Hanmi Financial Corp: financial statements, quarterly

HAFC · Nasdaq · CIK 1109242 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hafc.md) · [Financials](/companies/hafc/financials.md) · [Filings](/companies/hafc/filings.md) · [Insiders](/companies/hafc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hafc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [58.4](/filings/0000950170-25-067856.md) | [56.7](/filings/0000950170-25-105658.md) | [58.5](/filings/0001193125-25-271719.md) | [60.8 d](/filings/0001193125-26-082425.md) | [62.8](/filings/0001193125-26-214092.md) | [65.2](/filings/0001193125-26-339697.md) | [71.0](/filings/0001193125-25-271719.md) | [71.2 d](/filings/0001193125-26-082425.md) | [71.7](/filings/0001193125-26-214092.md) | [72.2](/filings/0001193125-26-339697.md) |
| Operating income | $m | not reported | not reported | [15.2](/filings/0000950170-25-067856.md) | [14.5](/filings/0000950170-25-105658.md) | [14.9](/filings/0001193125-25-271719.md) | [17.7 d](/filings/0001193125-26-082425.md) | [17.7](/filings/0001193125-26-214092.md) | [15.1](/filings/0001193125-26-339697.md) | [22.1](/filings/0001193125-25-271719.md) | [21.2 d](/filings/0001193125-26-082425.md) | [22.6](/filings/0001193125-26-214092.md) | [23.5](/filings/0001193125-26-339697.md) |
| Interest expense | $m | [39.2](/filings/0000950170-23-060872.md) | [44.0 d](/filings/0000950170-24-022986.md) | [48.9](/filings/0000950170-24-052648.md) | [50.0](/filings/0000950170-24-091398.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.9](/filings/0000950170-24-120861.md) | [8.8 d](/filings/0001193125-26-082425.md) | [6.6](/filings/0000950170-25-067856.md) | [6.0](/filings/0000950170-25-105658.md) | [6.2](/filings/0001193125-25-271719.md) | [7.6 d](/filings/0001193125-26-082425.md) | [7.4](/filings/0001193125-26-214092.md) | [6.1](/filings/0001193125-26-339697.md) | [9.4](/filings/0001193125-25-271719.md) | [8.9 d](/filings/0001193125-26-082425.md) | [7.9](/filings/0001193125-26-214092.md) | [8.5](/filings/0001193125-26-339697.md) |
| Net income | $m | [18.8](/filings/0000950170-24-120861.md) | [18.6 d](/filings/0001193125-26-082425.md) | [15.2](/filings/0000950170-25-067856.md) | [14.5](/filings/0000950170-25-105658.md) | [14.9](/filings/0001193125-25-271719.md) | [17.7 d](/filings/0001193125-26-082425.md) | [17.7](/filings/0001193125-26-214092.md) | [15.1](/filings/0001193125-26-339697.md) | [22.1](/filings/0001193125-25-271719.md) | [21.2 d](/filings/0001193125-26-082425.md) | [22.6](/filings/0001193125-26-214092.md) | [23.5](/filings/0001193125-26-339697.md) |
| Diluted EPS | $ per share | [0.62](/filings/0000950170-24-120861.md) | not reported | [0.50](/filings/0000950170-25-067856.md) | [0.48](/filings/0000950170-25-105658.md) | [0.49](/filings/0001193125-25-271719.md) | not reported | [0.58](/filings/0001193125-26-214092.md) | [0.50](/filings/0001193125-26-339697.md) | [0.73](/filings/0001193125-25-271719.md) | not reported | [0.75](/filings/0001193125-26-214092.md) | [0.79](/filings/0001193125-26-339697.md) |
| Basic EPS | $ per share | [0.62](/filings/0000950170-24-120861.md) | not reported | [0.50](/filings/0000950170-25-067856.md) | [0.48](/filings/0000950170-25-105658.md) | [0.49](/filings/0001193125-25-271719.md) | not reported | [0.59](/filings/0001193125-26-214092.md) | [0.50](/filings/0001193125-26-339697.md) | [0.73](/filings/0001193125-25-271719.md) | not reported | [0.76](/filings/0001193125-26-214092.md) | [0.79](/filings/0001193125-26-339697.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [7,350](/filings/0000950170-23-060872.md) | [7,570](/filings/0000950170-25-029782.md) | [7,512](/filings/0000950170-24-052648.md) | [7,586](/filings/0000950170-24-091398.md) | [7,712](/filings/0000950170-24-120861.md) | [7,678](/filings/0001193125-26-082425.md) | [7,729](/filings/0000950170-25-067856.md) | [7,862](/filings/0000950170-25-105658.md) | [7,857](/filings/0001193125-25-271719.md) | [7,869](/filings/0001193125-26-339697.md) | [7,839](/filings/0001193125-26-214092.md) | [8,001](/filings/0001193125-26-339697.md) |
| Total liabilities | $m | [6,687](/filings/0000950170-23-060872.md) | [6,868](/filings/0000950170-25-029782.md) | [6,809](/filings/0000950170-24-052648.md) | [6,879](/filings/0000950170-24-091398.md) | [6,976](/filings/0000950170-24-120861.md) | [6,946](/filings/0001193125-26-082425.md) | [6,978](/filings/0000950170-25-067856.md) | [7,100](/filings/0000950170-25-105658.md) | [7,077](/filings/0001193125-25-271719.md) | [7,073](/filings/0001193125-26-339697.md) | [7,036](/filings/0001193125-26-214092.md) | [7,189](/filings/0001193125-26-339697.md) |
| Shareholders' equity | $m | [663](/filings/0000950170-24-120861.md) | [702](/filings/0001193125-26-082425.md) | [703](/filings/0000950170-25-105658.md) | [707](/filings/0001193125-25-271719.md) | [737](/filings/0001193125-25-271719.md) | [732](/filings/0001193125-26-339697.md) | [751](/filings/0001193125-26-339697.md) | [763](/filings/0001193125-26-339697.md) | [780](/filings/0001193125-25-271719.md) | [796](/filings/0001193125-26-339697.md) | [803](/filings/0001193125-26-339697.md) | [813](/filings/0001193125-26-339697.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [29.5 d](/filings/0000950170-24-120861.md) | [9.6 d](/filings/0001193125-26-082425.md) | [30.0](/filings/0000950170-25-067856.md) | [2.1 d](/filings/0000950170-25-105658.md) | [6.7 d](/filings/0001193125-25-271719.md) | [13.8 d](/filings/0001193125-26-082425.md) | [26.4](/filings/0001193125-26-214092.md) | [(18.5) d](/filings/0001193125-26-339697.md) | [146 d](/filings/0001193125-25-271719.md) | [52.2 d](/filings/0001193125-26-082425.md) | [23.9](/filings/0001193125-26-214092.md) | [(8.8) d](/filings/0001193125-26-339697.md) |
| Capital expenditure | $m | [(1.3) d](/filings/0000950170-24-120861.md) | [2.1 d](/filings/0001193125-26-082425.md) | [0.8](/filings/0000950170-25-067856.md) | [0.8 d](/filings/0000950170-25-105658.md) | [0.2 d](/filings/0001193125-25-271719.md) | [0.8 d](/filings/0001193125-26-082425.md) | [0.3](/filings/0001193125-26-214092.md) | [0.6 d](/filings/0001193125-26-339697.md) | [0.6 d](/filings/0001193125-25-271719.md) | [0.9 d](/filings/0001193125-26-082425.md) | [0.5](/filings/0001193125-26-214092.md) | [1.1 d](/filings/0001193125-26-339697.md) |
| Dividends paid | $m | [7.7 d](/filings/0000950170-24-120861.md) | [7.6 d](/filings/0001193125-26-082425.md) | [7.7](/filings/0000950170-25-067856.md) | [7.6 d](/filings/0000950170-25-105658.md) | [7.6 d](/filings/0001193125-25-271719.md) | [7.5 d](/filings/0001193125-26-082425.md) | [8.2](/filings/0001193125-26-214092.md) | [8.3 d](/filings/0001193125-26-339697.md) | [8.1 d](/filings/0001193125-25-271719.md) | [8.1 d](/filings/0001193125-26-082425.md) | [8.4](/filings/0001193125-26-214092.md) | [8.5 d](/filings/0001193125-26-339697.md) |
| Share repurchases | $m | [1.9 d](/filings/0000950170-24-120861.md) | [0.7 d](/filings/0001193125-26-082425.md) | [1.6](/filings/0000950170-25-067856.md) | [2.7 d](/filings/0000950170-25-105658.md) | [1.4 d](/filings/0001193125-25-271719.md) | [0.6 d](/filings/0001193125-26-082425.md) | [1.1](/filings/0001193125-26-214092.md) | [1.6 d](/filings/0001193125-26-339697.md) | [4.7 d](/filings/0001193125-25-271719.md) | [2.0 d](/filings/0001193125-26-082425.md) | [4.8](/filings/0001193125-26-214092.md) | [4.8 d](/filings/0001193125-26-339697.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [30.4](/filings/0000950170-23-060872.md) | [30.4](/filings/0000950170-24-052648.md) | [30.4](/filings/0000950170-24-091398.md) | [30.3](/filings/0000950170-24-120861.md) | [30.1](/filings/0000950170-25-067856.md) | [30.1](/filings/0000950170-25-105658.md) | [30.0](/filings/0001193125-25-271719.md) | [30.1](/filings/0001193125-26-214092.md) | [30.1](/filings/0001193125-26-339697.md) | [29.9](/filings/0001193125-25-271719.md) | [29.8](/filings/0001193125-26-214092.md) | [29.7](/filings/0001193125-26-339697.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,649,255 at 2026-07-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-339697.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.